$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

$fold Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913061113 Filed on August 07, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$0.00	$10.64M
YoY Change	-100.0%	163.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.830M	$5.820M
YoY Change	-17.01%	-13.39%
% of Gross Profit
Research & Development	$10.73M	$13.72M
YoY Change	-21.85%	18.12%
% of Gross Profit
Depreciation & Amortization	$450.0K	$440.0K
YoY Change	2.27%	4.76%
% of Gross Profit
Operating Expenses	$16.01M	$19.98M
YoY Change	-19.91%	6.5%
Operating Profit	-$16.01M	-$9.347M
YoY Change	71.23%	-36.52%
Interest Expense	$9.000K	$15.00K
YoY Change	-40.0%	-63.41%
% of Operating Profit
Other Income/Expense, Net	$0.00	$21.00K
YoY Change	-100.0%
Pretax Income	-$15.35M	-$9.343M
YoY Change	64.28%	-26.09%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$15.35M	-$9.343M
YoY Change	64.28%	-26.09%
Net Earnings / Revenue		-87.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$309.4K	-$199.3K
COMMON SHARES
Basic Shares Outstanding	49.63M shares	46.38M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$74.20M	$95.80M
YoY Change	-22.55%	15.42%
Cash & Equivalents	$23.48M	$28.86M
Short-Term Investments	$50.70M	$66.90M
Other Short-Term Assets	$1.978M	$2.700M
YoY Change	-26.74%	-12.9%
Inventory
Prepaid Expenses
Receivables	$1.000M
Other Receivables	$0.00
Total Short-Term Assets	$77.18M	$105.7M
YoY Change	-26.98%	19.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.715M	$5.500M
YoY Change	-14.27%	189.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$442.0K	$400.0K
YoY Change	10.5%	33.33%
Total Long-Term Assets	$5.157M	$5.900M
YoY Change	-12.59%	168.18%
TOTAL ASSETS
Total Short-Term Assets	$77.18M	$105.7M
Total Long-Term Assets	$5.157M	$5.900M
Total Assets	$82.34M	$111.6M
YoY Change	-26.22%	23.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.000M	$9.100M
YoY Change	-1.1%	30.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$800.0K
YoY Change	-50.0%	-38.46%
Total Short-Term Liabilities	$9.967M	$17.81M
YoY Change	-44.04%	5.4%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$500.0K
YoY Change	-80.0%	25.0%
Other Long-Term Liabilities	$32.70M	$20.10M
YoY Change	62.69%	-29.23%
Total Long-Term Liabilities	$32.80M	$20.60M
YoY Change	59.22%	-28.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.967M	$17.81M
Total Long-Term Liabilities	$32.80M	$20.60M
Total Liabilities	$42.80M	$38.40M
YoY Change	11.46%	-15.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$351.7M
YoY Change
Common Stock	$391.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.56M	$73.17M
YoY Change
Total Liabilities & Shareholders Equity	$82.34M	$111.6M
YoY Change	-26.22%	23.59%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$15.35M	-$9.343M
YoY Change	64.28%	-26.09%
Depreciation, Depletion And Amortization	$450.0K	$440.0K
YoY Change	2.27%	4.76%
Cash From Operating Activities	-$10.26M	-$11.13M
YoY Change	-7.82%	5.0%
INVESTING ACTIVITIES
Capital Expenditures	-$210.0K	-$860.0K
YoY Change	-75.58%	681.82%
Acquisitions
YoY Change
Other Investing Activities	$7.300M	$16.74M
YoY Change	-56.39%	89.37%
Cash From Investing Activities	$7.100M	$15.88M
YoY Change	-55.29%	81.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-410.0K
YoY Change	-75.61%
NET CHANGE
Cash From Operating Activities	-10.26M	-11.13M
Cash From Investing Activities	7.100M	15.88M
Cash From Financing Activities	-100.0K	-410.0K
Net Change In Cash	-3.260M	4.340M
YoY Change	-175.12%	-332.09%
FREE CASH FLOW
Cash From Operating Activities	-$10.26M	-$11.13M
Capital Expenditures	-$210.0K	-$860.0K
Free Cash Flow	-$10.05M	-$10.27M
YoY Change	-2.14%	-2.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	398000	USD
CY2012Q4	fold	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	908000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	556000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-33256000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9343000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22480000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3000	USD
	fold	Beneficial Conversion Feature Related To Bridge Financing BeneficialConversionFeatureRelatedToBridgeFinancing	135000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82335000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	77178000	USD
CY2013Q2	us-gaap	Assets Assets	82335000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9967000	USD
CY2013Q2	fold	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	551000	USD
CY2013Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	100000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	39559000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8501000	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49631672	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49631672	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49631672	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49631672	shares
CY2012Q2	fold	Research Revenue ResearchRevenue	5477000	USD
	fold	Research Revenue ResearchRevenue	11591000	USD
CY2012Q2	fold	Collaboration Revenue CollaborationRevenue	5160000	USD
	fold	Collaboration Revenue CollaborationRevenue	6820000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	10637000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	18411000	USD
CY2012Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	13723000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9914000	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	442000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	862000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	19984000	USD
	us-gaap	Operating Expenses OperatingExpenses	38503000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9347000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20092000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	116000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	143000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	15000	USD
	us-gaap	Interest Expense InterestExpense	58000	USD
CY2012Q2	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	118000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	2494000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9343000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22480000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	16005000	USD
	us-gaap	Operating Expenses OperatingExpenses	33256000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16005000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15349000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-32807000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-32807000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-15349000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32807000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46870067	shares
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15349000	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	450000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	11000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42103642	shares
	us-gaap	Sales Revenue Net SalesRevenueNet	121875000	USD
	us-gaap	Operating Expenses OperatingExpenses	496500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-374625000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-360404000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-371922000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-20000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	13000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-20000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	13000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-20000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	13000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-12000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-11000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	3000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-12000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15361000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32818000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-351693000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3145000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	2494000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-27000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	2194000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3245000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-267000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-641000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3895000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19170000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	34839000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	71706000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3939000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-40806000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	726000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	840000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	995000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	63166000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	3190000	USD
	us-gaap	Interest Paid InterestPaid	50000	USD
	fold	Conversion Of Warrants To Common Stock ConversionOfWarrantsToCommonStock	386000	USD
	fold	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	148951000	USD
	fold	Accretion Of Redeemable Convertible Preferred Stock AccretionOfRedeemableConvertiblePreferredStock	802000	USD
	fold	Beneficial Conversion Feature Related To Issuance Of Series C Redeemable Convertible Preferred Stock BeneficialConversionFeatureRelatedToIssuanceOfSeriesCRedeemableConvertiblePreferredStock	19424000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24161000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	13865000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-199000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-10495000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25668000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28858000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23476000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-351696000	USD
CY2010Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4950000	shares
CY2010Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1900000	shares
CY2012Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	11500000	shares
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	33971000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	65137000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	25000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	65151000	USD
CY2012Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	99108000	USD
CY2012Q4	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	99122000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	23476000	USD
CY2013Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	50697000	USD
CY2013Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	18000	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	15000	USD
CY2013Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	50700000	USD
CY2013Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	74173000	USD
CY2013Q2	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	74176000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	37000	USD
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-11000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	USD
CY2012	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	33100000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	20800000	USD
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49621188	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49621188	shares
CY2013Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2013Q2	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3300000	USD
	fold	Fair Value Inputs Number Of Inputs Used In Fair Value Classification FairValueInputsNumberOfInputsUsedInFairValueClassification	6	item
CY2012	fold	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	500000	shares
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.7327	pure
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	1.1144	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0029	pure
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0011	pure
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y8M1D
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P8M1D
CY2013Q2	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-619000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1910000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-357000	USD
CY2013Q2	fold	Common Stock Voting Rights For Each Share Held CommonStockVotingRightsForEachShareHeld	1	item
CY2012Q1	us-gaap	Share Price SharePrice	5.70
CY2012Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	65600000	USD
CY2010Q1	fold	Stock Issued During Period Shares Collaboration Agreement StockIssuedDuringPeriodSharesCollaborationAgreement	4900000	shares
CY2010Q1	fold	Number Of Shares Of Common Stock Sold In One Unit NumberOfSharesOfCommonStockSoldInOneUnit	1	shares
CY2010Q1	fold	Number Of Warrants Sold In One Unit NumberOfWarrantsSoldInOneUnit	1	shares
CY2010Q1	fold	Portion Of Share Purchased In One Unit PortionOfSharePurchasedInOneUnit	0.375	shares
CY2010Q1	us-gaap	Share Price SharePrice	3.74
CY2010Q1	fold	Warrant Term WarrantTerm	P4Y
CY2010Q1	fold	Exercise Period Of Warrant On Or After Issued ExercisePeriodOfWarrantOnOrAfterIssued	P6M
CY2010Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	4.43
CY2010Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	18500000	USD
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1400000	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3157000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3145000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1757000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1583000	USD
	fold	Research Revenue ResearchRevenue	57493000	USD
	fold	Collaboration Revenue CollaborationRevenue	64382000	USD
CY2013Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10725000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	22714000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	338607000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4830000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9653000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	142266000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	46000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	111000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	14500000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	9000	USD
	us-gaap	Interest Expense InterestExpense	19000	USD
	us-gaap	Interest Expense InterestExpense	2441000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	252000	USD
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8708000	USD
	fold	Deemed Dividend DeemedDividend	19424000	USD
	fold	Preferred Stock Accretion PreferredStockAccretion	802000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1522000	USD
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1030000	USD
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9018000	USD
CY2013Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	398000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12657000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	418000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	889000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	525000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	522000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	45086000	USD
	fold	Share Based Compensation Non Employees ShareBasedCompensationNonEmployees	853000	USD
	fold	Stock Based License Payments StockBasedLicensePayments	1220000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-1910000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-388000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	1024000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1978000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	466000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9018000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	32709000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-252513000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	797876000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	848689000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18788000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-69601000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	143022000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193441000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5000000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	5587000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4255000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3341000	USD
	fold	Proceeds From Exercise Of Warrants Common And Preferred ProceedsFromExerciseOfWarrantsCommonAndPreferred	264000	USD
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	5611000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	4753000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	345590000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	23476000	USD
	us-gaap	Interest Paid InterestPaid	2133000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3157000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-357000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-2201000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-292000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	173000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2291000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	42434000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	27994000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	575000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	199000	USD
	us-gaap	Interest Paid InterestPaid	16000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9363000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22467000	USD
CY2013Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	50700000	USD
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1024000	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1978000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4715000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	442000	USD
CY2013Q2	us-gaap	Deferred Credits And Other Liabilities Noncurrent DeferredCreditsAndOtherLiabilitiesNoncurrent	32709000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	556000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	390696000	USD
CY2012Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	299000	USD
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.00	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.00	pure

Files In Submission

Name	View Source	Status
0001104659-13-061113-index-headers.html	Edgar Link	pending
0001104659-13-061113-index.html	Edgar Link	pending
0001104659-13-061113.txt	Edgar Link	pending
0001104659-13-061113-xbrl.zip	Edgar Link	pending
a13-13902_110q.htm	Edgar Link	pending
a13-13902_1ex10d5.htm	Edgar Link	pending
a13-13902_1ex10d6.htm	Edgar Link	pending
a13-13902_1ex10d7.htm	Edgar Link	pending
a13-13902_1ex10d8.htm	Edgar Link	pending
a13-13902_1ex31d1.htm	Edgar Link	pending
a13-13902_1ex31d2.htm	Edgar Link	pending
a13-13902_1ex32d1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
fold-20130630.xml	Edgar Link	completed
fold-20130630.xsd	Edgar Link	pending
fold-20130630_cal.xml	Edgar Link	unprocessable
fold-20130630_def.xml	Edgar Link	unprocessable
fold-20130630_lab.xml	Edgar Link	unprocessable
fold-20130630_pre.xml	Edgar Link	unprocessable
g139021kii001.jpg	Edgar Link	pending
g139021kki001.jpg	Edgar Link	pending
g139021kmi001.jpg	Edgar Link	pending
g139021koi001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

2013 Q2 Form 10-Q Financial Statement

#000110465913061113 Filed on August 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD AMICUS THERAPEUTICS, INC. Stock $fold

2013 Q2 Form 10-Q Financial Statement

#000110465913061113 Filed on August 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold